Can a 12-Week group program help women with trauma and suicidal thoughts?

NCT ID NCT07346638

Recruiting now Symptom relief Sponsor: Stanford University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests a new 12-week group therapy program called BEAR-SI for women aged 18-75 who have experienced interpersonal trauma and currently have suicidal thoughts. The program combines psychological skills, education about trauma, and physical self-defense training. The study aims to see if the program is feasible and whether it can improve coping confidence and reduce suicidal thinking.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Building Empowerment and Resilience (BEAR) group therapy program
What this could lead to: If successful, this could provide a new group therapy option to reduce suicidal thinking and improve coping confidence in trauma survivors.
What could go wrong: This is a very small pilot study (30 participants) testing feasibility only, so results may not be generalizable. The program is new and unproven for this specific use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder Depression depressive disorder post-traumatic stress disorder Suicidal Ideation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANXIETY DEPRESSION INTERPERSONAL TRAUMA PTSD SEXUAL ASSAULT SUICIDAL IDEATIONS

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Stanford University School of Medicine
RECRUITING

Stanford, California, 94305, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.